Omvoh Eli Lilly Australia Pty Ltd
Product name
Omvoh
Sponsor
Accepted date
Aug-2024
Active ingredients
mirikizumab
Proposed indication
Treatment of ulcerative colitis in adults who have not benefited from conventional treatments.
Application type
C (new indication)
Publication date
Aug-2024